C. Tsatalas

417 total citations
10 papers, 266 citations indexed

About

C. Tsatalas is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, C. Tsatalas has authored 10 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 5 papers in Genetics and 4 papers in Oncology. Recurrent topics in C. Tsatalas's work include Lymphoma Diagnosis and Treatment (7 papers), Viral-associated cancers and disorders (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). C. Tsatalas is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Viral-associated cancers and disorders (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). C. Tsatalas collaborates with scholars based in Greece, Belgium and United Kingdom. C. Tsatalas's co-authors include Meletios Α. Dimopoulos, Dimitrios Margaritis, George Bourikas, Evangelia Nakou, Anna V. Christophoridou, Christina Tsigalou, Ιoannis Kotsianidis, Irene Bouchliou, Anastasios Karadimitris and George Fountzilas and has published in prestigious journals such as Annals of Oncology, Leukemia and Seminars in Oncology.

In The Last Decade

C. Tsatalas

10 papers receiving 261 citations

Peers

C. Tsatalas

PFM

HEMAT

IMMUN

ONCOL

GENET

Auayporn Nademanee United States

Eduardo Ríos Spain

Nigel Patton New Zealand

Guy Cantin Canada

L. Tedeschi Italy

J Biggs Australia

Marjan Ertault France

Claudia Minotto Italy

Pierangelo Spedini Italy

Ruemu Birhiray United States

Auayporn Nademanee United States

C. Tsatalas

152 ×1.2

PFM

151 ×1.2

HEMAT

75 ×0.9

IMMUN

105 ×1.3

ONCOL

99 ×1.3

GENET

Citations per year, relative to C. Tsatalas C. Tsatalas (= 1×) peers Auayporn Nademanee

Countries citing papers authored by C. Tsatalas

Since Specialization

Citations

This map shows the geographic impact of C. Tsatalas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Tsatalas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Tsatalas more than expected).

Fields of papers citing papers by C. Tsatalas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Tsatalas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Tsatalas. The network helps show where C. Tsatalas may publish in the future.

Co-authorship network of co-authors of C. Tsatalas

This figure shows the co-authorship network connecting the top 25 collaborators of C. Tsatalas. A scholar is included among the top collaborators of C. Tsatalas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Tsatalas. C. Tsatalas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Anagnostopoulos, Konstantinos, et al.. (2008). Effect of HbS in the determination of HbA₂ with the Menarini HA‐8160 analyzer and comparison with other instruments. International Journal of Laboratory Hematology. 31(6). 665–672. 9 indexed citations

Kotsianidis, Ιoannis, Irene Bouchliou, Evangelia Nakou, et al.. (2008). Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS). Leukemia. 23(3). 510–518. 108 indexed citations

Economopoulos, T., A. Psyrri, Meletios Α. Dimopoulos, et al.. (2007). CEOP-21 Versus CEOP-14 Chemotherapy With or Without Rituximab for the First-Line Treatment of Patients With Aggressive Lymphomas: Results of the HE22A99 Trial of the Hellenic Cooperative Oncology Group. The Cancer Journal. 13(5). 327–334. 16 indexed citations

Papaxoinis, George, George Fountzilas, Dimitra Rontogianni, et al.. (2007). Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG). Annals of Oncology. 19(4). 780–786. 27 indexed citations

Economopoulos, T., Sotirios G. Papageorgiou, Meletios Α. Dimopoulos, et al.. (2005). Non-Hodgkin’s Lymphomas in Greece according to the WHO Classification of Lymphoid Neoplasms. Acta Haematologica. 113(2). 97–103. 26 indexed citations

Tsatalas, C., Dimitrios Margaritis, Anastasios J. Karayiannakis, et al.. (2004). Extramedullary plasmacytoma: report of two cases with uncommon presentation. Annals of Hematology. 84(3). 188–191. 7 indexed citations

Dimopoulos, Meletios Α., C. Tsatalas, Athanassios Zomas, et al.. (2003). Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone. Seminars in Oncology. 30(2). 265–269. 39 indexed citations

Economopoulos, Theofanis, Meletios Α. Dimopoulos, S. Mellou, et al.. (2002). Treatment of intermediate‐ and high‐grade non‐Hodgkin's lymphoma using CEOP versus CNOP. European Journal Of Haematology. 68(3). 135–143. 10 indexed citations

Economopoulos, Theofanis, Meletios Α. Dimopoulos, Christos Nikolaidis, et al.. (2000). Burkitt's lymphoma in Greek adults. Leukemia Research. 24(12). 993–998. 3 indexed citations

10.

Pectasides, Dimitrios, T. Economopoulos, G. Kouvatseas, et al.. (2000). Anthracycline-Based Chemotherapy of Primary Non-Hodgkin’s Lymphoma of the Testis: The Hellenic Cooperative Oncology Group Experience. Oncology. 58(4). 286–292. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact